Navigation Links
E. coli persists against antibiotics through HipA-induced dormancy
Date:1/15/2009

nase inhibitors will bind to and block HipA's active site. If they work, persistent cells, which are already rare, would vanish." Persistent cells are a one-in-a-million-cells occurrence because HipA is normally kept in check by a protein called HipB.

Persistence is common in "biofilms," bacterial colonies that become attached to a surface in a supportive matrix. Drug-resistant biofilms cause about 60 percent of infections in the developed world, the researchers note.

Overexpression of HipA previously had been associated with cell dormancy and bacterial persistence. Evidence had pointed to kinase activity.

Schumacher, Brennan and colleagues demonstrated the molecular details of HipA's role in multidrug tolerance and HipB's role keeping HipA under wraps in a series of experiments:

  • Using X-ray crystallography to determine and then compare the structures of several HipA complexes, they showed that HipA has a serine/threonine protein kinase fold and that it binds tightly to adenosine triphosphate (ATP), a common characteristic of kinases. Phosphorylation occurs when an enzyme binds to both ATP and to its target protein.
  • Assays of candidate proteins to identify a target for HipA found that EF-Tu interacts strongly with HipA in the presence of ATP. EF-Tu is the most abundant protein in E.coli and plays an essential role in protein synthesis.
  • Subsequent experiments and structural analysis of a HipA/EF-Tu peptide complex indicated that HipA phosphorylates EF-Tu, freezing up the bacteria's protein-making machinery and inducing dormancy.
  • To analyze how HipB normally prevents HipA's function, the team solved the structure of the HipB/DNA/HipA complex. HipB tightly binds two HipA molecules in a sandwich-like structure.
  • HipB does not block HipA's active site, but inactivates it by forcing it into an "open" position. "Proteins move a lot to function, they open and close - think of a clam she
    '/>"/>

Contact: Scott Merville
smerville@mdanderson.org
713-792-0661
University of Texas M. D. Anderson Cancer Center
Source:Eurekalert  

Page: 1 2 3

Related medicine news :

1. Direct recording shows brain signal persists even in dreamless sleep
2. Raised Breast Cancer Risk Persists After Combo HRT Stopped
3. Facial asymmetry persists despite surgery to correct congenital deformity
4. HIV persists in the gut despite long-term HIV therapy
5. Chronic infection persists by targeting stromal cell network in lymphoid organs
6. AMA Claims Victory With Record Breaking Settlement in Case Against Insurer
7. Report Finds That Raids Are Not an Effective Tool Against Human Trafficking
8. Maslinic acid provides a natural defense against colon cancer
9. Nose-spray vaccine against botulism effective in first tests
10. New Drug May Work Better Against Chemo Side Effects
11. Researchers Report Progress in Fight Against Fat
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
E. coli persists against antibiotics through HipA-induced dormancy
E. coli persists against antibiotics through HipA-induced dormancy
(Date:12/5/2009)... Wind Turbines are popping up in the most unusual places, and to ... , ... (PRWEB) December 5, 2009 -- Who would have thought that ... Inc. of Fort Worth, Texas has announced a new line of turbines, ...
(Date:12/4/2009)... NEW YORK, Dec. 4 Care Investment Trust Inc. ... that its Board of Directors has declared a dividend of $0.17 ... December 22, 2009 to common shareholders of record on December 14, ... ,, Care Investment Trust Inc. is a real estate investment and ...
(Date:12/4/2009)... won the Patient,s Choice Award as the favorite dispensary ... by the online website, www.weedmaps.com. Despite only ... selected Medithrive as the preeminent location for accessing medicinal ... of Medithrive confirms the obvious: a dispensary which caters ...
(Date:12/4/2009)... WASHINGTON, Dec. 4 The American Association of Homes and ... that the Community Living and Supportive Services (CLASS) provisions ... provisions are essential for providing support to elders, people with ... to pass a health care reform bill that will make ...
(Date:12/4/2009)... two-day free health clinic sponsored by the National Association of ... is not just for the sick but also for anyone ... All participants in the health clinic will receive preventive primary ... large free clinic events this fall in Houston, New Orleans ...
Breaking Medicine News(10 mins):Health News:Distributor Announces New Applications for Wind Turbines 2Health News:Distributor Announces New Applications for Wind Turbines 3Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2Health News:Free Health Clinic Event Is Not Just for the Sick 2
... Inc. (IPM) today announced it is one of ... by The Wall Street Journal and Winning Workplaces. ... ( www.wsj.com/smallbusiness ). IPM provides project management and ... including the life sciences, food and beverage, healthcare, ...
... the combination of low plasma levels of antioxidants and blue ... of the eye disease age-related macular degeneration (AMD), according to ... Ophthalmology , one of the JAMA/Archives journals. , ... the authors write as background information in the article. "While ...
... first-ever report,by the United Nations Secretary-General, Ban Ki-Moon, on ... the Campaign to End,Fistula announced a fourfold increase in ... report, the campaign now works to prevent and treat,fistula ... Arab States. When it,was launched in 2003, it covered ...
... Awareness Day Encourages Latinos to Get Tested, LOS ... make up almost half of all newly diagnosed HIV/AIDS ... nationally., -- A week of activities aimed at ... with National Latino AIDS Awareness Day,observed on October 15., ...
... a greater effect on women, study found , , MONDAY, Oct. ... more your brain shrinks, a new study has found. ... lot, you,re going to hurt your brain," said Rajesh Miranda, ... Texas A&M Health Science Center College of Medicine. "This is ...
... Integrated Medical,Systems, Inc., a medical technology systems integrator ... that it has received,510(k) clearance from the U.S. ... 1000(TM) "suitcase" intensive care unit (ICU)., "FDA ... accomplishment for the,company as we continue to demonstrate ...
Other Medicine News:Health News: Integrated Project Management Named a "Top Small Workplace" by The Wall Street Journal and Winning Workplaces 2Health News: Integrated Project Management Named a "Top Small Workplace" by The Wall Street Journal and Winning Workplaces 3Health News:Sunlight exposure plus low antioxidant levels may place older adults at risk for eye disease 2Health News:Campaign to End Fistula Quadruples In Size, Reaching Over 45 Countries, Says New Report 2Health News:Campaign to End Fistula Quadruples In Size, Reaching Over 45 Countries, Says New Report 3Health News:Nearly Half of Newly Diagnosed HIV/AIDS Cases in Los Angeles County Are Among Latinos 2Health News:Excess Drinking Shrinks the Brain 2Health News:Integrated Medical Systems Receives FDA Clearance for World's First 'Suitcase' Intensive Care Unit 2Health News:Integrated Medical Systems Receives FDA Clearance for World's First 'Suitcase' Intensive Care Unit 3
(Date:12/4/2009)... Hospira, Inc. (NYSE: HSP ), a ... announced the launch of its next-generation 50 mL and ... solutions, and now offers a complete size range (50 ... VisIV product. The launch of the 50 mL and ...
(Date:12/4/2009)... ANNAPOLIS, Md., Dec. 4 PharmAthene, Inc. (NYSE ... medical countermeasures against biological and chemical threats, announced ... a study demonstrating the effectiveness of Valortim® in ... White (NZW) rabbit. The data are being ...
(Date:12/4/2009)... Mass., Dec. 4 Axsun Technologies, Inc., a wholly-owned ... announced the initial development and successful testing of a ... Axsun believes this proprietary optical engine design raises the ... laser-based designs for swept source OCT light sources. ...
Breaking Medicine Technology:Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 2Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 3Hospira Expands VisIV(TM) Portfolio to Offer Complete Range of Environmentally Friendly I.V. Containers 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 3Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 4Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 5C Section Stress Could Alter Babys Immune Cells 50672 1C Section Stress Could Alter Babys Immune Cells 50672 2CyberGlove Systems Hosts Worldwide Contest for New Motion Capture Technology Applications 50667 1CyberGlove Systems Hosts Worldwide Contest for New Motion Capture Technology Applications 50667 2CyberGlove Systems Hosts Worldwide Contest for New Motion Capture Technology Applications 50667 3If 2 Painkillers Are Banned What Next 3F 50662 1If 2 Painkillers Are Banned What Next 3F 50662 2If 2 Painkillers Are Banned What Next 3F 50662 3If 2 Painkillers Are Banned What Next 3F 50662 4
... May 15 Patients with breast or,colorectal cancer, ... expect,further treatment advances with Avastin(R) (bevacizumab) and Herceptin(R),(trastuzumab) ... the 44th,American Society of Clinical Oncology (ASCO) annual ... 30,000 medical experts will attend the meeting which,is ...
... Cytopia Limited,(ASX: CYT) today announced that the abstract ... Annual Meeting of the American Society,of Clinical Oncology (ASCO) ... (http://www.asco.org ) from 9pm on Thursday 15 May (US ... of CYT997, a novel,cytotoxic and vascular disrupting agent, in ...
Other Medicine Technology:New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 2New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 3New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 4New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 5New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 6
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: